Yüklüyor......
Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade
The recent development of high-throughput genomics has revolutionized personalized medicine by identifying key pathways and molecular targets controlling tumor progression and survival. Mitogen-activated protein kinase (MAPK) pathways are examples of such targets, and inhibitors against these pathwa...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7177307/ https://ncbi.nlm.nih.gov/pubmed/32260561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21072531 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|